GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Senomyx Inc (NAS:SNMX) » Definitions » EV-to-EBIT

Senomyx (Senomyx) EV-to-EBIT : -28.55 (As of May. 05, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Senomyx EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Senomyx's Enterprise Value is $72.98 Mil. Senomyx's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 was $-2.56 Mil. Therefore, Senomyx's EV-to-EBIT for today is -28.55.

The historical rank and industry rank for Senomyx's EV-to-EBIT or its related term are showing as below:

SNMX's EV-to-EBIT is not ranked *
in the Chemicals industry.
Industry Median: 17.23
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Senomyx's Enterprise Value for the quarter that ended in Jun. 2018 was $43.35 Mil. Senomyx's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 was $-2.56 Mil. Senomyx's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was -5.90%.


Senomyx EV-to-EBIT Historical Data

The historical data trend for Senomyx's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senomyx EV-to-EBIT Chart

Senomyx Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.16 -19.38 -11.41 -2.89 -34.71

Senomyx Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.26 -1.76 -34.71 -14.78 -16.96

Competitive Comparison of Senomyx's EV-to-EBIT

For the Specialty Chemicals subindustry, Senomyx's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senomyx's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Senomyx's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Senomyx's EV-to-EBIT falls into.



Senomyx EV-to-EBIT Calculation

Senomyx's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=72.980/-2.556
=-28.55

Senomyx's current Enterprise Value is $72.98 Mil.
Senomyx's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senomyx  (NAS:SNMX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Senomyx's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2018 ) =EBIT / Enterprise Value (Q: Jun. 2018 )
=-2.556/43.34696
=-5.90 %

Senomyx's Enterprise Value for the quarter that ended in Jun. 2018 was $43.35 Mil.
Senomyx's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senomyx EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Senomyx's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Senomyx (Senomyx) Business Description

Traded in Other Exchanges
N/A
Address
Senomyx Inc manufactures and sells a variety of favors for the packaged food, beverage, and ingredient supply industries. The firm's product portfolio has three primary categories: sweetmyx, savorymyx, and bittermyx. Sweetmyx ingredients are used to increase a product's sweet taste while reducing sugar usage. Savorymyx ingredients are used to increase a product's savory flavors as well as reduce MSG, nucleotides, and sodium in food and beverage products. Bittermyx ingredients are used to reduce a product's bitter taste.
Executives
Christopher J Twomey director 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121
John Poyhonen director, officer: President & CEO 11088 N TORREY PINES RD, C/O SENOMYX INC, LA JOLLA CA 92037
Stephen A Block director INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Mary Ann Gray director 201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
Richard R Mashaal 10 percent owner C/O RIMA SENVEST MANAGEMENT, L.L.C., 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Senvest Management, Llc 10 percent owner 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Michael E Herman director CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
David B Berger officer: Sr. V.P. Gen. Counsel & Sec. 11045 ROSELLE STREET, SAN DIEGO CA 92121
Dennis F Obrien director SENOMYX INC, 11099 NORTH TORREY PINES ROAD, LA JOLLA CA 92037
Harry J Leonhardt officer: SVP, Gen.Counsel & Corp. Sec. C/O HALOZYME THERAPEUTICS, INC., 11388 SORRENTO VALLEY BLVD., SAN DIEGO CA 92121
Mark Leschly director RHO CAPITAL PARTNERS, INC., 152 W 57TH ST 23RD FL, NEW YORK NY 10019
David Schnell director 525 UNIVERSITY AVE, SUITE 1350, PALO ALTO CA 94301
Timothy J Wollaeger director
Beeley Nigel R A officer: VP Discovery ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVER SAN DIEGO CA 92121
Rho Management Trust I 10 percent owner C/O RHO CAPITAL PARTNERS, INC., 152 W. 57TH STREET, 23RD FLOOR, NEW YORK NY 10019